Literature DB >> 11572145

Current laboratory methods for biological threat agent identification.

E A Henchal1, J D Teska, G V Ludwig, D R Shoemaker, J W Ezzell.   

Abstract

The authors present an integrated approach for the identification of biological threat agents. The methods used have been used extensively in field exercises and during response to incidents of biological terrorism. A diagnostic system, which integrates the clinical diagnosis or medical intelligence with immunodiagnostic tests, rapid gene amplification assays, and standard culture, provides results of the highest quality and confidence. In the future, selected reagents and technologies will be distributed through a network of civilian and military laboratories.

Mesh:

Substances:

Year:  2001        PMID: 11572145

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  4 in total

1.  Affinity capture mass spectrometry of biomarker proteins using peptide ligands from biopanning.

Authors:  Erin M Johnson; Walther R Ellis; Linda S Powers; Vicki H Wysocki
Journal:  Anal Chem       Date:  2009-08-01       Impact factor: 6.986

2.  Analysis of suspicious powders following the post 9/11 anthrax scare.

Authors:  Brandon Wills; Jerrold Leikin; James Rhee; Bijan Saeedi
Journal:  J Med Toxicol       Date:  2008-06

Review 3.  The evolving field of biodefence: therapeutic developments and diagnostics.

Authors:  James C Burnett; Erik A Henchal; Alan L Schmaljohn; Sina Bavari
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

4.  Early indicators of exposure to biological threat agents using host gene profiles in peripheral blood mononuclear cells.

Authors:  Rina Das; Rasha Hammamieh; Roger Neill; George V Ludwig; Steven Eker; Patrick Lincoln; Preveen Ramamoorthy; Apsara Dhokalia; Sachin Mani; Chanaka Mendis; Christiano Cummings; Brian Kearney; Atabak Royaee; Xiao-Zhe Huang; Chrysanthi Paranavitana; Leonard Smith; Sheila Peel; Niranjan Kanesa-Thasan; David Hoover; Luther E Lindler; David Yang; Erik Henchal; Marti Jett
Journal:  BMC Infect Dis       Date:  2008-07-30       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.